ARC Therapy™ was shown to be safe and effective in a global pivotal study*.
90% of participants improved either upper limb strength or function*.
Improvement was demonstrated in participants up to 34 years after their spinal cord injury*.
87% of participants also reported an improvement in their overall quality of life*
EINDHOVEN, Netherlands, May 20, 2024 – ONWARD Medical NV (Euronext: ONWD), a medical technology company behind innovative therapies* to restore movement, function and independence in people with spinal injuries. spinal cord (SCI), today announced the publication of results from the global pivotal Up-LIFT study in Nature Medicine.
The study met all primary safety and efficacy endpoints, and ARC-EX therapy demonstrated significant improvements in upper extremity strength, function, and sensation in people with chronic quadriplegia due to cervical spinal cord injury.
Find the full press release below:
Contact for Public Relations in France for ONWARD Medical: Gabriel Rafaty, Aimpact _ [email protected]